ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries
Date | 18-06-2021

Reports are increasing on the emergence of COVID-19 associated mucormycosis (CAM) globally, driven particularly by low- and middle-income countries. The recent unprecedented surge of CAM in India has drawn worldwide attention. More than 28,252 mucormycosis cases are counted and India is the first …

Invitation to participate in survey to establish the first WHO fungal priority pathogens list
Date | 17-06-2021

WHO is inviting experts and professionals involved in anti-fungal healthcare delivery and/or human mycology research to participate in a global survey to develop the first fungal priority pathogens list (FPPL) of public health importance. Recognizing the public health threat of …

5th ECMM Educational Symposium- RARE YEASTS – A GROWING THREAT, 1-2 July 2021, ONLINE
Date | 08-06-2021

In view of the current state of the COVID 19 Pandemic, and following consultation with the ECMM Board, ECMM Educational Officer and Congress Care, it was decided to change the Educational Symposium  on “Rare Yeasts – A Growing Threat” on …

Covid-Associated Mucormycosis (CAM)
Date | 18-05-2021

Since the onset of the COVID 19 pandemic there have been multiple reports across India and neighbor countries of very high incidence of mucormycosis among patients with COVID 19 especially in those who are diabetic and those who have received …

Webinar on “Global guideline for the diagnosis and management of rare mould infections” May 26th, 5-6pm CET
Date | 06-05-2021

Early in 2021, 45 authors from all UN regions published on behalf of ECMM and MSGERC the “Global guideline for the diagnosis and management of rare mould infections” in Lancet Infectious Diseases. It rapidly became a sought after resource. Strengthening …